Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Short N-Terminal Fragment in Front of the A1 Domain of Von Willebrand Factor Prevents the A1 from Binding the Platelet By Masking a Region Clustered By Type 2B VWD Mutations

Wei Deng, PhD, Yingchun Wang, PhD, Pete Lollar, MD, Renhao Li, PhD

Blood (2016) 128 (22): 553.

https://doi.org/10.1182/blood.V128.22.553.553

Published: 2016

Journal Articles

Platelet Membranes and Activation Pathway Determine Inhibitory Activity of Anti-Factor VIII C2 Domain Antibodies

Madhumouli Chatterjee, PhD, Shannon L. Meeks, MD, Valerie Anne Novakovic, MS, Pete Lollar, MD, Gary E. Gilbert, MD

Blood (2016) 128 (22): 2567.

https://doi.org/10.1182/blood.V128.22.2567.2567

Published: 2016

Journal Articles

Characterization of Factor VIII Immune Complexes By Analytical Ultracentrifugation

Pete Lollar, MD, Ernest T. Parker, John F. Healey, Christopher B. Doering, PhD

Blood (2016) 128 (22): 3787.

https://doi.org/10.1182/blood.V128.22.3787.3787

Published: 2016

Journal Articles

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

Glaivy Batsuli, MD, Wallace Hunter Baldwin, BS, John F Healey, BS, Ernest T Parker, BS, Courtney Cox, MSc, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2016) 128 (22): 3762.

https://doi.org/10.1182/blood.V128.22.3762.3762

Published: 2016

Journal Articles

Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers

Glaivy Batsuli, MD, John Healey, BS, Ernest Parker, BS, Wallace Hunter Baldwin, BS, Courtney Cox, MSc, Brenda Nguyen, BS, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2015) 126 (23): 1066.

https://doi.org/10.1182/blood.V126.23.1066.1066

Published: 2015

Journal Articles

Anti-Factor VIII C1 Domain Antibodies Are Present in the Plasmas of Patients with Hemophilia and Inhibitors

Glaivy Batsuli, MD, Courtney Cox, M.S., John F. Healey, B.S., Pete Lollar, MD, Shannon L Meeks, MD

Blood (2014) 124 (21): 1482.

https://doi.org/10.1182/blood.V124.21.1482.1482

Published: 2014

Journal Articles

Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease

Joerg Kahle, PhD, Christoph Königs, MD, PhD, Anja Naumann, Thomas Klingebiel, MD, John F Healey, Ernest T Parker, B.A., Pete Lollar, MD, Dirk Schwabe, MD, Manuela Krause, MD

Blood (2013) 122 (21): 1110.

https://doi.org/10.1182/blood.V122.21.1110.1110

Published: 2013

Journal Articles

High-Resolution Mapping of B-Cell Epitopes on the Factor VIII C2 Domain Using Surface Plasmon Resonance

Phuong-Cac Nguyen, Ph.D., Kenneth B Lewis, Ph.D., Jason T. Schuman, Ph.D., Shannon L. Meeks, MD, John F. Healey, B.S., Pete Lollar, MD, Kathleen P. Pratt, Ph.D.

Blood (2011) 118 (21): 203.

https://doi.org/10.1182/blood.V118.21.203.203

Published: 2011

Journal Articles

Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model.

Shannon Meeks, MD, Ernest T Parker, BS, Amy L. Dunn, MD, John F Healey, BS, Pete Lollar, MD

Blood (2009) 114 (22): 27.

https://doi.org/10.1182/blood.V114.22.27.27

Published: 2009

Journal Articles

Cooperative Interaction Between Classical and Non-Classical Factor VIII C2 Domain Antibody Epitopes.

Ana G Antun, MD, Shannon L Meeks, MD, John F Healey, BS, Ernest T Parker, BS, Pete Lollar, MD

Blood (2009) 114 (22): 219.

https://doi.org/10.1182/blood.V114.22.219.219

Published: 2009

Journal Articles

Herpes Simplex Virus Initiates the Intrinsic Pathway of Coagulation.

Edwin S Gershom, Michael R Sutherland, PhD, Pete Lollar, MD, Ed L. Pryzdial, PhD

Blood (2009) 114 (22): 3173.

https://doi.org/10.1182/blood.V114.22.3173.3173

Published: 2009

Journal Articles

A Subset of High Titer Acquired Hemophilia Patients May Benefit from Treatment with High Dose Factor VIII.

Shannon Meeks, MD, John F Healey, BS, Ernest T Parker, BS, Pete Lollar, MD

Blood (2009) 114 (22): 3476.

https://doi.org/10.1182/blood.V114.22.3476.3476

Published: 2009

Journal Articles

Development of a Novel Recombinant Factor VIII Product through Transgene Engineering and Lentiviral-Driven Expression

Keith W Kerstann, PhD, Pete Lollar, MD, H. Trent Spencer, PhD, Gabriela Denning, PhD, Lajos Baranyi, PhD, Robert Keefe, PhD, Boro Dropulic, MBA, PhD, Christopher B Doering, PhD

Blood (2008) 112 (11): 3072.

https://doi.org/10.1182/blood.V112.11.3072.3072

Published: 2008

Journal Articles

Non-Classical Anti-Factor VIII C2 Domain Antibodies Are Pathogenic in a Murine in Vivo Bleeding Model.

Shannon Meeks, MD, John F. Healey, BS, Ernest T. Parker, BS, Rachel T. Barrow, BS, John (Pete) Lollar, MD

Blood (2008) 112 (11): 2027.

https://doi.org/10.1182/blood.V112.11.2027.2027

Published: 2008

Journal Articles

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Shannon L. Meeks, MD, John F. Healey, BS, Rachel T. Barrow, BS, Ernest T. Parker, BS, Pete Lollar, MD

Blood (2007) 110 (11): 784.

https://doi.org/10.1182/blood.V110.11.784.784

Published: 2007

Journal Articles

Factor VIIIa Decay Due to A2 Subunit Dissociation Is Regulated by the A1 Domain.

Ernest T. Parker, BS, Christopher B. Doering, PhD, Pete Lollar, MD

Blood (2005) 106 (11): 1009.

https://doi.org/10.1182/blood.V106.11.1009.1009

Published: 2005

Journal Articles

Comparative Immunogenicity of Two Forms of Porcine Factor VIII in Cynomolgus Monkeys.

Garrett E. Bergman, MD, Pete Lollar, MD

Blood (2004) 104 (11): 3079.

https://doi.org/10.1182/blood.V104.11.3079.3079

Published: 2004

NARROW

A Short N-Terminal Fragment in Front of the A1 Domain of Von Willebrand Factor Prevents the A1 from Binding the Platelet By Masking a Region Clustered By Type 2B VWD Mutations

Platelet Membranes and Activation Pathway Determine Inhibitory Activity of Anti-Factor VIII C2 Domain Antibodies

Characterization of Factor VIII Immune Complexes By Analytical Ultracentrifugation

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers

Anti-Factor VIII C1 Domain Antibodies Are Present in the Plasmas of Patients with Hemophilia and Inhibitors

Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease

High-Resolution Mapping of B-Cell Epitopes on the Factor VIII C2 Domain Using Surface Plasmon Resonance

Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model.

Cooperative Interaction Between Classical and Non-Classical Factor VIII C2 Domain Antibody Epitopes.

Herpes Simplex Virus Initiates the Intrinsic Pathway of Coagulation.

A Subset of High Titer Acquired Hemophilia Patients May Benefit from Treatment with High Dose Factor VIII.

Development of a Novel Recombinant Factor VIII Product through Transgene Engineering and Lentiviral-Driven Expression

Non-Classical Anti-Factor VIII C2 Domain Antibodies Are Pathogenic in a Murine in Vivo Bleeding Model.

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Factor VIIIa Decay Due to A2 Subunit Dissociation Is Regulated by the A1 Domain.

Comparative Immunogenicity of Two Forms of Porcine Factor VIII in Cynomolgus Monkeys.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only